Corrigendum to "XIAOPI formula promotes breast cancer chemosensitivity via inhibiting CXCL1/HMGB1-mediated autophagy" [Biomed. Pharmacother. 120 (2019) 109519]
Biomed Pharmacother. 2022 May:149:112867.
doi: 10.1016/j.biopha.2022.112867.
Epub 2022 Mar 31.
1 Research Center of Integrative Medicine, School of basic medical sciences, Guangzhou University of Chinese Medicine; Integrative Research Laboratory of Breast Cancer, the Second Clinical College of Guangzhou University of Chinese Medicine, Guangzhou, Guangdong, China; Guangdong Provincial Key Laboratory of Clinical Research on Traditional Chinese Medicine Syndrome, Guangdong Provincial Academy of Chinese Medical Sciences, Guangdong Provincial Hospital of Chinese Medicine, Guangzhou 510006, Guangdong, China.
2 Research Center of Integrative Medicine, School of basic medical sciences, Guangzhou University of Chinese Medicine; Integrative Research Laboratory of Breast Cancer, the Second Clinical College of Guangzhou University of Chinese Medicine, Guangzhou, Guangdong, China; Guangdong Provincial Key Laboratory of Clinical Research on Traditional Chinese Medicine Syndrome, Guangdong Provincial Academy of Chinese Medical Sciences, Guangdong Provincial Hospital of Chinese Medicine, Guangzhou 510006, Guangdong, China; Post-doctoral Research Center, Guangzhou University of Chinese Medicine, Guangzhou, Guangdong, China.
3 State Key Laboratory of Quality Research in Chinese Medicine, Institute of Chinese Medical Sciences, University of Macau, Taipa, Macau.
4 School of Chinese Medicine, Hong Kong Baptist University, Hong Kong.
5 Research Center of Integrative Medicine, School of basic medical sciences, Guangzhou University of Chinese Medicine; Integrative Research Laboratory of Breast Cancer, the Second Clinical College of Guangzhou University of Chinese Medicine, Guangzhou, Guangdong, China; Guangdong Provincial Key Laboratory of Clinical Research on Traditional Chinese Medicine Syndrome, Guangdong Provincial Academy of Chinese Medical Sciences, Guangdong Provincial Hospital of Chinese Medicine, Guangzhou 510006, Guangdong, China. Electronic address: linyi1942@126.com.
6 Research Center of Integrative Medicine, School of basic medical sciences, Guangzhou University of Chinese Medicine; Integrative Research Laboratory of Breast Cancer, the Second Clinical College of Guangzhou University of Chinese Medicine, Guangzhou, Guangdong, China; Guangdong Provincial Key Laboratory of Clinical Research on Traditional Chinese Medicine Syndrome, Guangdong Provincial Academy of Chinese Medical Sciences, Guangdong Provincial Hospital of Chinese Medicine, Guangzhou 510006, Guangdong, China; Post-doctoral Research Center, Guangzhou University of Chinese Medicine, Guangzhou, Guangdong, China; State Key Laboratory of Quality Research in Chinese Medicine, Institute of Chinese Medical Sciences, University of Macau, Taipa, Macau; School of Chinese Medicine, Hong Kong Baptist University, Hong Kong. Electronic address: wangzhiyu@gzucm.edu.cn.